Navigation Links
Raptor Pharmaceuticals Provides Update on Targeting Platforms
Date:11/6/2008

Enters Collaboration on Receptor Associated Protein (RAP)

Supports NeuroTrans(TM) Platform with Japanese Patent

NOVATO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced updates on its preclinical program which utilizes drug-targeting platforms derived from the human receptor-associated protein ("RAP") and related proteins. The Company signed a collaborative research agreement with the Brigham and Women's Hospital involving the characterization of certain modified RAP proteins. At the Hospital, this research will be conducted in the laboratory of Dr. Stephen Blacklow. The Company has also announced today a patent issuance in Japan relating to the NeuroTrans(TM) program.

The collaborative research with Brigham and Women's Hospital focuses on RAP sequence variants engineered for improved binding affinity and enhanced stability in complex with receptors. Under terms of the agreement, the Blacklow Laboratory, a substantial contributor to the study of RAP and its interactions, and researchers at Raptor will test RAP sequence variants designed to withstand temperatures, pH and other conditions that normally cause native receptor complexes to fail.

Todd C. Zankel, Ph.D., Chief Scientific Officer of Raptor, commented, "We are thrilled with the opportunity to work with Dr. Stephen Blacklow's lab to develop effective RAP-based sequence variants that could increase the utility of RAP-based targeting platforms and potential therapeutics. RAP-based peptides engineered to withstand certain conditions, such as low pH, may bind better and demonstrate enhanced biological potency compared to proteins or peptides derived from the naturally occurring RAP sequence and will complement our growing in-house set of targeting peptides."

Raptor also announced that the Patent Office of Japan will issue Raptor's patent application 2003-515208 entitled "Compositio
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
2. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
3. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
4. Raptor Pharmaceuticals Provides Update of Product Programs
5. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
6. Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD
7. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
8. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
9. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
10. Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura
11. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., Ohio, Nov. 19 Riverain Medical a... with leading Canadian medical imaging distributor...maging and OnGuard Chest Xray CAD. The exclusive a...dical,s products to the Canadian market through Ch...nnel. ,, SoftView Enhanced Chest Imaging increa...
(Date:11/19/2009)...BRIDGE, Mass., Nov. 19 Ligon Disco...microarray technology to find drugs against high-v...1M in seed financing led by incTANK Ventures. The ...al discovery campaign that will screen over 100 hi...ment, incTANK Ventures General Partner Christian B...
(Date:11/19/2009)...art of International Internet Week of Action ,...re/ -- The U.S. Food and Drug Administration today...effort, called the International Internet Week of ...volving medical products. ,, (Logo: http://www... During the effort, the FDA,s Office of Criminal I...
Breaking Medicine Technology:Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Cancer Gap Between Whites Blacks May Be Biological in Part 50988 1Cancer Gap Between Whites Blacks May Be Biological in Part 50988 2New Clues to Race Gap in Breast Cancer Outcomes 50984 1New Clues to Race Gap in Breast Cancer Outcomes 50984 2New Clues to Race Gap in Breast Cancer Outcomes 50984 3Riverside Partners Completes Growth Equity Investment in Vocollect the Leader in Voice Solutions for Supply Chain and Healthcare Workforce Management 50980 1Riverside Partners Completes Growth Equity Investment in Vocollect the Leader in Voice Solutions for Supply Chain and Healthcare Workforce Management 50980 2Riverside Partners Completes Growth Equity Investment in Vocollect the Leader in Voice Solutions for Supply Chain and Healthcare Workforce Management 50980 3
...NAPOLIS, Nov. 6 Eli Lilly and Company,(NYSE: LLY...the National,Committee for Quality Assurance (NCQA...anagement Program. Tools that Empower(TM) Depress...d care organizations to assist in further driving ...ve Disorder (MDD). Lilly created the,program in re...
...ology may improve quality of recovery compared wit...ocedure, SUNNYVALE, Calif., Nov. 6 Starion Instr...nnounced that a study published in,the Annals of O... of,Starion,s proprietary Tissue Welding Technolog...ificantly less intraoperative blood loss and lower...
Other Medicine Technology:Lilly Receives NCQA Design Certification for Depression Care Management Program 2Lilly Receives NCQA Design Certification for Depression Care Management Program 3Study Finds Starion Instruments' Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients 2
(Date:11/21/2009)... 21 Milvia Lopez, by her attorney ...y filed suit, in Supreme Court, New York County, b...that while Ms. Lopez underwent a routine transesop...SPITAL , doctors used an HIV infected scope exposi...several hours after being discharged from the proc...
(Date:11/21/2009)...NH based medical credentialing software company In...rm a partnerhsip with Amerinet, Inc., the leading ...ll help to transform quality care within the healt...ovember 21, 2009 -- ISG Group, LLC, doing business...nt with Amerinet Inc., a leading national healthca...
(Date:11/21/2009)...New Haven Dental Group merges their practice with ... , (PRWEB) November 21, 20...tners Dr. David Gibson, Dr. Dean Cloutier, Dr. Joh...ed their growing practice with that of esteemed co...n decided he wanted to retire from dentistry in or...
(Date:11/20/2009)...ov. 20 The American Ac... health care reform legislation released this week...nsurance individual coverage mandate. The actuarie...ill minimize adverse selection stemming from more ...he bill. ,, "The individual mandate language sh...
(Date:11/20/2009)...., Nov. 20 Rates of infe...aked in late October, but the pandemic flu virus c...l age groups, including the elderly, according to ...SE: DGX ), the world,s leading provider of diagn... its most recent Quest Diagnostics Health Trends(T...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:New Haven Dental Group Expands Their Vision 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...igh Definition MS (HDMS) System to Aid ...Nov. 8 Swedish-based,biotechnology firm Medivir A...to hasten its drug discovery efforts in the area o...ure.,Installed in June, the Synapt High Definition...
...ielding drugs, patient health has suffered, resear...News) -- Pulling the painkillers Vioxx and Bextra ...ended up harming their stomachs, a new study sugge...ordered off the market in 2004-2005, researchers s...
... inVentiv Health, Inc.,(Nasdaq: VTIV ) today anno...ill make a presentation at the 2007 Credit Suisse ...on November 13-17, 2007. The conference will,featu...ce on Tuesday, November 13 at 4,p.m. MST at the Ar...
... following is a,statement of William V. Corr, Exec...Sounding an alarm that should be heard in Congress...or Disease Control and Prevention (CDC),reported t... The CDC reported that 20.8 percent of U.S. adults...
...s Pennsylvanians to Get a Flu Shot, HARRISBURG, P...first state laboratory-confirmed case of influenza...ay., "The announcement of our first confirmed flu.... Calvin B.,Johnson said. "While this is only the ...
... World Fact Book, an overwhelming majority, 90 per...filiation. , Today, our society is more religiou...o important that mental health professionals under... general population, says Dowd. As co-editor of Th...
Other Medicine News:Health News:Medivir Reshapes Drug Discovery 2Health News:Medivir Reshapes Drug Discovery 3Health News:Vioxx Ban Tied to Rise in Serious GI Trouble 2Health News:Vioxx Ban Tied to Rise in Serious GI Trouble 3Health News:Vioxx Ban Tied to Rise in Serious GI Trouble 4Health News:inVentiv Health to Present at the 2007 Credit Suisse Healthcare Conference 2Health News:CDC Reports that Adult Smoking Declines Have Stalled; Elected Officials Should Step up Fight Against Tobacco 2Health News:CDC Reports that Adult Smoking Declines Have Stalled; Elected Officials Should Step up Fight Against Tobacco 3Health News:Health Department Reports State's First Lab-Confirmed Influenza Case of the Season 2
... macular degeneration (AMD) could not expect their...eatment. Now, the Opal Photoactivator laser from L... offers patients renewed hope., ,Lumenis desig...photodynamic therapy with verteporfin, a drug prod...
Eye Bank Kerato Analyzer
...ients who have cataract and contracted pupils! The...MMA ring for the expansion of the pupil during pha...g for a single use. Indication: Expansion of the p...ave pupils which will not dilate adequately. Impor...
PVP Perforated Plugs
Medicine Products: